Yahoo
Paris - Delayed Quote EUR

Valerio Therapeutics Société anonyme (ALVIO.PA)

0.4250 +0.0020 (+0.47%)
As of 1:56:58 PM GMT+1. Market Open.
View in AlphaSpace Currency in EUR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
5,549
2,573
1,793
1,800
1,443
Cost of Revenue
1,148
847
513
533
514
Gross Profit
4,401
1,726
1,280
1,267
929
Operating Expense
7,183
2,276
17,768
20,320
18,042
Operating Income
-2,782
-550
-16,488
-19,053
-17,113
Net Non Operating Interest Income Expense
-142
-292
171
-38
-2,549
Pretax Income
-6,721
-4,637
-23,553
-20,325
-19,273
Tax Provision
377
261
377
17
285
Net Income Common Stockholders
-7,051
-4,898
-23,919
-20,344
-19,562
Diluted NI Available to Com Stockholders
-7,051
-4,898
-23,919
-20,344
-19,562
Basic EPS
-0.02
-0.02
--
-0.15
-0.18
Diluted EPS
-0.02
-0.02
--
-0.15
-0.18
Basic Average Shares
273,962.2680
274,054.2490
--
135,209.4060
105,746
Diluted Average Shares
274,054.2490
274,054.2490
153,878.1210
142,074.5510
115,288.6980
Total Operating Income as Reported
-2,783
-549
-16,489
-19,053
-17,115
Total Expenses
8,331
3,123
18,281
20,853
18,556
Net Income from Continuing & Discontinued Operation
-7,051
-4,898
-23,919
-20,344
-19,562
Normalized Income
-7,051
-4,898
-23,919
-20,344
-19,562
Interest Income
102
86
485
28
16
Interest Expense
147
281
178
138
2,189
Net Interest Income
-142
-292
171
-38
-2,549
EBIT
-6,574
-4,356
-23,375
-20,187
-17,084
EBITDA
-1,360
542
-12,061
-18,444
-17,083
Reconciled Cost of Revenue
1,148
847
513
533
514
Reconciled Depreciation
5,214
4,898
11,314
1,743
-167
Net Income from Continuing Operation Net Minority Interest
-7,051
-4,898
-23,919
-20,344
-19,562
Normalized EBITDA
-1,360
542
-12,061
-18,444
-17,083
Tax Rate for Calcs
0
0.0003
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 12/8/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: